Opthea
Entry
2022
Hold
4yr
Status
Active
Who owns Opthea?
Opthea is an Australian Biotech company, currently owned by Abingworth since 2022.
Hand-verified · updated 2026-07-08
Open JSON · CC-BY
More from Abingworth Clinical Co-Development Fund 2
Other portfolio companies in the same fund.
USMore Abingworth portfolio companies
From the same investor, across funds.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Opthea?
Opthea is currently owned by Abingworth, through Abingworth Clinical Co-Development Fund 2, since 2022.
When did Abingworth acquire Opthea?
Abingworth acquired Opthea in 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue